Drug Search Results
More Filters [+]

Modipafant

Alternative Names: modipafant
Latest Update: 2020-03-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: PAF Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Singapore General Hospital
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Modipafant

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Dengue

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Cel01

P2

Withdrawn

Dengue

2019-08-08

Recent News Events

Date

Type

Title